Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.10
+0.06 (1.19%)
At close: May 12, 2025, 4:00 PM
5.34
+0.24 (4.71%)
After-hours: May 12, 2025, 7:14 PM EDT
Personalis Employees
As of December 31, 2024, Personalis had 229 total employees, including 228 full-time and 1 part-time employees. The number of employees increased by 4 or 1.78% compared to the previous year.
Employees
229
Change (1Y)
4
Growth (1Y)
1.78%
Revenue / Employee
$374,210
Profits / Employee
-$367,100
Market Cap
450.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PSNL News
- 6 days ago - Personalis, Inc. (PSNL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Personalis Reports First Quarter 2025 Financial Results - Business Wire
- 14 days ago - Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study - Business Wire
- 20 days ago - Personalis to Announce First Quarter 2025 Financial Results - Business Wire
- 20 days ago - Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection - Business Wire
- 6 weeks ago - Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 2 months ago - New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Business Wire
- 2 months ago - Personalis, Inc. (PSNL) Q4 2024 Earnings Call Transcript - Seeking Alpha